In a pivotal breakthrough, researchers from the University of Kentucky have revealed that ponesimod, an FDA-approved drug for multiple sclerosis (MS), displays significant potential as a treatment for Alzheimer’s disease.
Scientists from Stanford Medicine have discovered a gene variant, DR4 allele, that provides protection against both Alzheimer’s and Parkinson’s disease. Analyzing data from various continents, researchers found that this gene…
In a significant leap forward in Alzheimer's disease (AD) research, scientists from Massachusetts General Hospital (MGH) have developed a groundbreaking 3D cellular model.
Alzheimer’s disease is a type of dementia that causes memory, thinking and behavior problems. It is the most common reasons of dementia.